Stock Analysis of Alivus Life Sciences Limited (ALIVUS) - Birds Eye View

Intraday Price/Volume Analysis of Alivus Life Sciences Limited
Current Price Price Change Change % Open High Low Volume
1021.00 -1.000 -0.098 1020.00 1027.80 1015.40 6459
Intraday Screeners on Price Volume
As of-29-Jul-25 11:36


1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ALIVUS
Close 1022.00
Change -6.40 / 0.622 %
Volume 58140.00
Vol Change 8180.00 / 16.37 %
IndustryDrugs & Pharma
SectorHealthcare
TSR Strength Index
Technical StrengthBearish
Growth Index Very Low Growth Stock
Value Index Very Low Value Stock
Profitability Index Good Profitability
Stability Index Excellent Stability


Fundamental View of Alivus Life Sciences Limited
PE (TTM)

28.36

Very Poor
Price / Book

5.16

Very Poor
Price / Sales

5.51

Very Poor
Piotroski F Score

6.0

Good
Market Cap

12522.87 (Cr)

Enterprise Value

12223.85 (Cr)

ROA (TTM)

14.90

Good
ROE (TTM)

18.20

Good
Net Margin (TTM)

19.42

Good
Revenue

5.64 %

22832.10 M
Net Profit

0.842 %

4708.90 M
Debt to Equity

0.0010

Excellent
Altman Z Score

17.29

Excellent
Quick Ratio

2.85

Good
Cash Ratio

0.893

Not Good


Highs/Lows of Alivus Life Sciences Limited
PeriodOld priceStock ReturnNifty 50HighLowHigh DateLow Date
One Week1057.203.33 % 1.63 % 1067.001011.3022-Jul-2525-Jul-25
Two Week1072.904.74 % 1.60 % 1102.701011.3015-Jul-2525-Jul-25
One Month1001.302.07 % 3.73 % 1102.70982.4015-Jul-2501-Jul-25
Three Month1050.802.74 % 1.45 % 1225.10982.4015-May-2501-Jul-25
Six Months1153.2511.38 % 7.51 % 1251.00850.0006-Feb-2507-Apr-25
One year850.7020.14 % 0.620 % 1335.10842.5516-Sep-2429-Jul-24
Two year660.3554.77 % 25.63 % 1335.10596.0016-Sep-2416-Aug-23


Technical View of Alivus Life Sciences Limited
RSI

45.87

Neutral
MACD

0.146

Mild Bearish
ADX

18.67

Neutral
Super Trend

1080.57

Mild Bearish
Williams %R

-78.78

Neutral
CCI

-57.03

Neutral


EMA 5

1027.14

Strong Bearish
EMA 15

1033.07

Mild Bearish
EMA 50

1036.69

Strong Bearish
EMA 100

1043.19

Mild Bearish
SMA 100

1046.01

Mild Bearish
SMA 200

1057.87

Whipsaw
SMA 5 / 20

1023.84 / 1035.09

Mild Bearish
SMA 15 / 50

1038.95 / 1032.96

Mild Bullish
SMA 50 / 200

1032.96 / 1057.87

Mild Bearish




Charts of Alivus Life Sciences Limited


Returns of Alivus Life Sciences Limited with Peers
Period / StockALIVUSBLUEJETSANOFIVIJAYA
1 Week-3.33%-21.01%-2.07%12.60%
1 Mth2.07%-8.06%-6.48%15.33%
3 Mth-2.74%11.84%-4.50%9.92%
6mth-11.38%38.81%10.21%22.57%
1 Year20.14%78.16%-13.25%43.75%
2 Year54.77%--16.52%151.68%
5 Years---23.61%-
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Alivus Life Sciences Limited with Peers
Ratio / StockALIVUSBLUEJETSANOFIVIJAYA
PE28.3638.4833.6281.79
P/B5.1613.9116.2216.37
ROA14.9028.6625.8613.03
ROE18.2036.1548.2520.10
Debt To Equity0.00100.00310.00620.0291
Revenue22832.10 M
5.64 % 		10299.90 M
44.74 % 		20132.00 M
29.39 % 		6813.90 M
24.38 %
Net Income4708.90 M
0.842 % 		3052.00 M
86.38 % 		4133.00 M
31.45 % 		1430.80 M
20.41 %


Technicals of Alivus Life Sciences Limited with Peers
Technical / StockALIVUSBLUEJETSANOFIVIJAYA-
ADX18.6724.8015.8044.56
CMF0.0230-0.335-0.4150.384
MFI70.8328.6349.5989.79
RSI45.8735.9036.6964.09
MACD Abv SignalFalseFalseFalseTrue
Price Above 50 MAFalseFalseFalseTrue-
Price Above 200 MAFalseTrueFalseTrue-


About : Alivus Life Sciences Limited

Address : OIA House, Mumbai, India, 400099
Tel : 91 22 6829 7979
URL : https://www.alivus.com
Code : ALIVUS, ISIN : INE03Q201024, Exchange : NSE, Country : India
Fiscal Year End : March

Alivus Life Sciences Limited engages in the development, manufacture, and marketing of non-commoditized active pharmaceutical ingredients for various chronic therapeutic areas in India. The company offers various APIs, such as olmesartan, telmisartan, perindopril, atovaquone, solifenacin, mirabegron, sitagliptin, zonisamide, adapalene, and rosuvastatin. It also provides contract development and manufacturing services to a range of multinational corporations and specialty companies. The company's APIs are used in various therapeutic segments, including cardiovascular disease, central nervous system disorders, diabetes, gastrointestinal health, oncology, pain management, and anti-infectives. It also exports its products to Europe, North America, Latin America, Japan, and internationally. The company was formerly known as Glenmark Life Sciences Limited and changed its name to Alivus Life Sciences Limited in December 2024. The company was incorporated in 2011 and is based in Mumbai, India. Alivus Life Sciences Limited is a subsidiary of Nirma Limited.
Quick Overview of Birds Eye View